These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 28803984)

  • 1. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
    Hira T; Koga T; Sasaki K; Hara H
    Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
    Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
    Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
    Suga T; Kikuchi O; Kobayashi M; Matsui S; Yokota-Hashimoto H; Wada E; Kohno D; Sasaki T; Takeuchi K; Kakizaki S; Yamada M; Kitamura T
    Mol Metab; 2019 Jan; 19():1-12. PubMed ID: 30416006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
    Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose.
    Powell DR; Smith M; Greer J; Harris A; Zhao S; DaCosta C; Mseeh F; Shadoan MK; Sands A; Zambrowicz B; Ding ZM
    J Pharmacol Exp Ther; 2013 May; 345(2):250-9. PubMed ID: 23487174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight.
    Wang F; Yoder SM; Yang Q; Kohan AB; Kindel TL; Wang J; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(10):G807-15. PubMed ID: 26336929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
    Mayer F; Gunawan AL; Tso P; Aponte GW
    Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans.
    Wu T; Zhao BR; Bound MJ; Checklin HL; Bellon M; Little TJ; Young RL; Jones KL; Horowitz M; Rayner CK
    Am J Clin Nutr; 2012 Jan; 95(1):78-83. PubMed ID: 22158727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes: a randomized trial.
    Takebayashi K; Hara K; Terasawa T; Naruse R; Suetsugu M; Tsuchiya T; Inukai T
    Endocr J; 2017 Sep; 64(9):923-931. PubMed ID: 28824041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incretin secretion in humans is under the influence of cannabinoid receptors.
    Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of glucose-dependent insulinotropic polypeptide in diet-induced obesity.
    Seino Y; Yamazaki Y
    J Diabetes Investig; 2022 Jul; 13(7):1122-1128. PubMed ID: 35452190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release.
    Dobbins RL; Greenway FL; Chen L; Liu Y; Breed SL; Andrews SM; Wald JA; Walker A; Smith CD
    Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(11):G946-54. PubMed ID: 25767259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans.
    Kuhre RE; Gribble FM; Hartmann B; Reimann F; Windeløv JA; Rehfeld JF; Holst JJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G622-30. PubMed ID: 24525020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents.
    Moss CE; Marsh WJ; Parker HE; Ogunnowo-Bada E; Riches CH; Habib AM; Evans ML; Gribble FM; Reimann F
    Diabetologia; 2012 Nov; 55(11):3094-103. PubMed ID: 22872212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooking enhances beneficial effects of pea seed coat consumption on glucose tolerance, incretin, and pancreatic hormones in high-fat-diet-fed rats.
    Hashemi Z; Yang K; Yang H; Jin A; Ozga J; Chan CB
    Appl Physiol Nutr Metab; 2015 Apr; 40(4):323-33. PubMed ID: 25794240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats.
    Nakajima S; Hira T; Hara H
    Br J Nutr; 2015 May; 113(9):1477-88. PubMed ID: 25827219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.